ANNA ZELICHENOK: Open Payments
NPI 1376782680 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,341 in 98 payments from 20 companies in 2025. Trend: 2023 $1,862 · 2024 $1,622 · 2025 $2,341
Food & beverage: $2,181Education: $160
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $363 |
| HARMONY BIOSCIENCES LLC | 10 | $279 |
| Insmed, Inc. | 17 | $234 |
| GlaxoSmithKline, LLC. | 13 | $220 |
| Viatris Specialty LLC | 8 | $188 |
| AstraZeneca Pharmaceuticals LP | 7 | $169 |
| Actelion Pharmaceuticals US, Inc. | 6 | $121 |
| Axsome Therapeutics, Inc. | 4 | $106 |
| Grifols USA, LLC | 3 | $97 |
| Lilly USA, LLC | 1 | $95 |
Products named: DUPIXENT, Arikayce, WAKIX, YUPELRI, TEZSPIRE, NUCALA, UPTRAVI, Sunosi.
Industry payments across KY — which companies pay providers there.
